The JAK2 V617F mutation is rare in RARS but common in RARS-T

Leukemia. 2006 Nov;20(11):2060-1. doi: 10.1038/sj.leu.2404373. Epub 2006 Aug 24.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anemia, Refractory / classification
  • Anemia, Refractory / epidemiology
  • Anemia, Refractory / genetics*
  • Anemia, Sideroblastic / classification
  • Anemia, Sideroblastic / epidemiology
  • Anemia, Sideroblastic / genetics*
  • Diagnosis, Differential
  • Female
  • Humans
  • Incidence
  • Janus Kinase 2 / genetics*
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / classification
  • Myelodysplastic Syndromes / epidemiology
  • Myelodysplastic Syndromes / genetics*
  • Myeloproliferative Disorders / classification
  • Myeloproliferative Disorders / epidemiology
  • Myeloproliferative Disorders / genetics*
  • Point Mutation

Substances

  • JAK2 protein, human
  • Janus Kinase 2